Transcatheter Heart Valve Replacement and Repair Market

Transcatheter Heart Valve Replacement & Repair Market (Procedure: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair, and Transcatheter Pulmonary Valve Replacement) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Transcatheter Heart Valve Replacement & Repair Market Outlook 2031

  • The global industry was valued at US$ 3.4 Bn in 2022
  • It is projected to advance at a CAGR of 9.7% from 2023 to 2031 to reach more than US$ 8.0 Bn by the end of 2031

Analysts’ Viewpoint

Rise in prevalence of valvular heart disease is the major factor driving the global transcatheter heart valve replacement & repair market. Advancements in technology and increase in adoption of these procedures by physicians and patients are expected to propel market development. Ongoing research & development aimed at improving current transcatheter heart valve replacement & repair devices for better patient outcomes are fueling industry progress.

Development of devices that can be fully retrievable after implantation, allowing for greater flexibility and safety during the procedure, offers attractive opportunities for market players. Companies are developing strategies to navigate the regulatory and reimbursement environments in different regions and make their products more accessible to patients.

Transcatheter Heart Valve Replacement And Repair Market

Global Transcatheter Heart Valve Replacement & Repair Market Introduction

Transcatheter heart valve replacement & repair refers to a minimally invasive procedure used to replace or repair heart valves that are not functioning properly. This procedure involves inserting a catheter, which is a thin, flexible tube, through a small incision in the skin and threading it through the blood vessels to reach the heart.

Transcatheter heart valve replacement & repair procedures are typically used to treat valvular heart disease, a condition in which heart valves are damaged or not functioning properly. The most common type of valvular heart disease is aortic stenosis, which occurs when the aortic valve becomes narrowed, making it difficult for blood to flow from the heart to the rest of the body.

During the procedure, a new valve is inserted into the heart through the catheter and positioned inside the diseased valve. The new valve then takes over the function of regulating blood flow from the heart. In some cases, the procedure could involve repairing the existing valve using specialized devices inserted through the catheter.

Transcatheter heart valve replacement & repair procedures offer several advantages over traditional open-heart surgery, including reduced recovery time, less pain, and fewer complications. These are also less invasive and can be performed on patients who may not be good candidates for open-heart surgery.

Rise in Prevalence of Cardiovascular Diseases

Increase prevalence of cardiovascular diseases is a major driver of the global transcatheter heart valve replacement & repair market size. Cardiovascular disease is a leading cause of death globally, and valvular heart disease is a significant contributor to this burden. Valvular heart disease could occur as a result of age-related degeneration, congenital defects, infections, or other underlying medical conditions.

Transcatheter heart valve replacement and repair procedures offer a less invasive alternative to traditional open-heart surgery, making them a preferred treatment option for patients with valvular heart disease who are at high risk for surgery. Hence, the market has been growing rapidly, driven in part by increase in prevalence of valvular heart disease.

The geriatric population is also contributing to the growth of the market. The risk of developing valvular heart disease increases with age. This propels demand for transcatheter heart valve replacement & repair.

Technological Advancement Driving Global Transcatheter Heart Valve Replacement & Repair Market

Significant advancements in the development of transcatheter heart valve technologies have been made in the last decade. These advancements have led to the development of new and improved transcatheter heart valve devices that are more durable, safer, and easier to implant.

Some of the technological advancements that have driven the market include development of new materials that are biocompatible & resistant to wear and tear; usage of 3D printing to create customized heart valves; and development of imaging and navigation technologies that enable more precise placement of the heart valve.

Miniaturization of devices is another major technological advancement, which has enabled the development of smaller and more flexible delivery systems for transcatheter heart valves. This has made it possible to perform TAVR medical procedures on a large number of patients, including those with smaller vessels or complex anatomies.

Technological advancements in the field of transcatheter heart valve replacement and repair have led to improved patient outcomes, reduced procedural risks, and increased access to treatment options for patients with valvular heart disease. These factors are expected to accelerate market development in the next few years.

Rise in Adoption of TAVR as Treatment Option for Patients with Severe Aortic Stenosis

In terms of procedure, the transcatheter aortic valve replacement (TAVR) segment accounted for the largest global transcatheter heart valve replacement & repair market share in 2022. TAVR is a minimally invasive procedure used to replace a diseased or damaged aortic valve without the need for open-heart surgery.

TAVR has been increasingly adopted as a treatment option for patients with severe aortic stenosis who are at high risk for traditional open-heart surgery. Technological advancements, increase in awareness about the benefits of minimally invasive procedures, and aging population have driven the global market in the past few years.

Surge in Preference for TAVR among Patients with Aortic Stenosis

Based on indication, the aortic stenosis segment dominated the global market in 2022. Aortic stenosis is a condition, in which the aortic valve of the heart becomes narrowed, leading to restricted blood flow from the heart to the rest of the body. This could cause symptoms such as chest pain, shortness of breath, and fainting.

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that can be used to replace a damaged or diseased aortic valve without open-heart surgery. TAVR has become an increasingly popular treatment option among patients with aortic stenosis, especially for those who are considered to be at high-risk for traditional open-heart surgery.

Diagnosis, Patient Selection, and Post-procedural Care Offered by Hospitals

In terms of end-user, the hospitals segment held significant share of the global market in 2022. Transcatheter heart valve replacement & repair procedures are typically performed in a hospital setting. Hospitals are often the primary point of care for patients with valvular heart disease. Hospitals are also involved in the diagnosis, patient selection, and post-procedural care of patients undergoing transcatheter heart valve replacement & repair procedures. Thus, hospitals play a critical role in the overall patient journey and are an important stakeholder in the market.

However, outpatient transcatheter heart valve replacement & repair procedures are gaining popularity, and there could be a shift toward ambulatory surgery centers (ASCs) and other outpatient settings. This is likely to restrain the hospitals segment in the near future.

Regional Analysis of Global Transcatheter Heart Valve Replacement & Repair Market

As per transcatheter heart valve replacement & repair market trends, North America was the largest market for transcatheter heart valve replacement & repair in 2022. The market in the region is driven by high prevalence of valvular heart disease, increase in adoption of transcatheter heart valve replacement & repair procedures, and favorable reimbursement landscape.

Europe was the second largest market for transcatheter heart valve replacement & repair in 2022. Countries such as Germany, France, and the U.K. accounted for significant share of the market in Europe. The market in Europe is driven by aging population, rise in prevalence of valvular heart disease, and favorable reimbursement policies.

Asia Pacific is likely to be the fastest growing market for transcatheter heart valve replacement & repair during the forecast period. The market in the region is projected to be driven by increase in geriatric population, rise in incidence of valvular heart disease, and improving healthcare infrastructure. China and Japan are expected to be the largest markets in the region.

Analysis of Key Players

Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by leading players in the global transcatheter heart valve replacement & repair market. Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, JenaValve Technology, Inc., Meril Life Sciences, Sahajanand Medical Technologies Limited, MicroPort Scientific Corporation, Venus Medtech (Hangzhou), Inc., Suzhou Jiecheng Medical Technology Co. Ltd., Peijia Medical Limited, and Blue Sail Medical Co., Ltd. are the prominent players in the market.

Key Developments in Global Transcatheter Heart Valve Replacement & Repair Market

  • In 2020, CryoLife announced the acquisition of Ascyrus Medical, a company that develops devices for the treatment of aortic disease, including transcatheter aortic valve replacement procedures
  • In 2020, Edwards Lifesciences announced collaboration with Bay Labs to develop artificial intelligence (AI) software to improve the detection of heart disease
  • In 2020, Medtronic announced receipt of FDA approval for its Intrepid TMVR system, which is used to repair the mitral valve

The market report profiles key players based on parameters such as company overview, financial overview, business strategies, portfolio, segments, and recent developments.

Global Transcatheter Heart Valve Replacement & Repair Market Snapshot

Attribute

Detail

Size in 2022

US$ 3.4 Bn

Forecast (Value) in 2031

More than US$ 8.0 Bn

Growth Rate (CAGR)

9.7%

Forecast Period

2023–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Procedure
    • Transcatheter Aortic Valve Replacement (TAVR)
    • Transcatheter Mitral Valve Repair (TMVR)
    • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Indication
    • Aortic Stenosis
    • Mitral Regurgitation
    • Aortic Regurgitation
    • Mitral Stenosis
    • Tricuspid Regurgitation
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Catheterization Laboratories

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries

Companies Profiled

  • Abbott Laboratories
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • JenaValve Technology, Inc.
  • Meril Life Sciences
  • Sahajanand Medical Technologies Limited
  • MicroPort Scientific Corporation
  • Venus Medtech (Hangzhou) Inc.
  • Suzhou Jiecheng Medical Technology Co. Ltd.
  • Peijia Medical Limited
  • Blue Sail Medical Co., Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global transcatheter heart valve replacement & repair market in 2022?

The global industry was valued at US$ 3.4 Bn in 2022.

How big will the transcatheter heart valve replacement & repair industry be in 2031?

It is projected to reach more than US$ 8.0 Bn by 2031.

What will be the CAGR of the transcatheter heart valve replacement & repair business during the forecast period?

The business is anticipated to advance at a CAGR of 9.7% from 2023 to 2031.

Which are the prominent trends that affect market growth?

Increase in number of cardiovascular disease patients globally and technological advancements are driving the global market.

Which region will account for major share during the forecast period?

North America is projected to account for leading share during the forecast period.

Who are the prominent transcatheter heart valve replacement & repair players?

Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, JenaValve Technology, Inc., Meril Life Sciences, Sahajanand Medical Technologies Limited, MicroPort Scientific Corporation, Venus Medtech (Hangzhou), Inc., Suzhou Jiecheng Medical Technology Co. Ltd., Peijia Medical Limited, and Blue Sail Medical Co., Ltd. are the prominent players in the global market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transcatheter Heart Valve Replacement & Repair Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Technological Advancements

    5.2. Disease Prevalence & Incidence Rate Globally With Key Countries

    5.3. Key Industry Events

    5.4. COVID-19 Impact Analysis

6. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Procedure

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Procedure, 2017–2031

        6.3.1. Transcatheter Aortic Valve Replacement (TAVR)

        6.3.2. Transcatheter Mitral Valve Repair (TMVR)

        6.3.3. Transcatheter Pulmonary Valve Replacement (TPVR)

    6.4. Market Attractiveness Analysis, by Procedure

7. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. Aortic Stenosis

        7.3.2. Mitral Regurgitation

        7.3.3. Aortic Regurgitation

        7.3.4. Mitral Stenosis

        7.3.5. Tricuspid Regurgitation

    7.4. Market Attractiveness Analysis, by Indication

8. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Cardiac Catheterization Laboratories

        8.3.3. Ambulatory Surgical Centers

    8.4. Market Attractiveness Analysis, by End-user

9. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017–2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Procedure, 2017–2031

        10.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        10.2.2. Transcatheter Mitral Valve Repair (TMVR)

        10.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

    10.3. Market Value Forecast, by Indication, 2017–2031

        10.3.1. Aortic Stenosis

        10.3.2. Mitral Regurgitation

        10.3.3. Aortic Regurgitation

        10.3.4. Mitral Stenosis

        10.3.5. Tricuspid Regurgitation

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Cardiac Catheterization Laboratories

        10.4.3. Ambulatory Surgical Centers

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Procedure

        10.6.2. By Indication

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Procedure, 2017–2031

        11.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        11.2.2. Transcatheter Mitral Valve Repair (TMVR)

        11.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

    11.3. Market Value Forecast, by Indication, 2017–2031

        11.3.1. Aortic Stenosis

        11.3.2. Mitral Regurgitation

        11.3.3. Aortic Regurgitation

        11.3.4. Mitral Stenosis

        11.3.5. Tricuspid Regurgitation

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Cardiac Catheterization Laboratories

        11.4.3. Ambulatory Surgical Centers

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Procedure

        11.6.2. By Indication

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Procedure, 2017–2031

        12.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        12.2.2. Transcatheter Mitral Valve Repair (TMVR)

        12.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

    12.3. Market Value Forecast, by Indication, 2017–2031

        12.3.1. Aortic Stenosis

        12.3.2. Mitral Regurgitation

        12.3.3. Aortic Regurgitation

        12.3.4. Mitral Stenosis

        12.3.5. Tricuspid Regurgitation

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Cardiac Catheterization Laboratories

        12.4.3. Ambulatory Surgical Centers

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Procedure

        12.6.2. By Indication

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Procedure, 2017–2031

        13.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        13.2.2. Transcatheter Mitral Valve Repair (TMVR)

        13.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

    13.3. Market Value Forecast, by Indication, 2017–2031

        13.3.1. Aortic Stenosis

        13.3.2. Mitral Regurgitation

        13.3.3. Aortic Regurgitation

        13.3.4. Mitral Stenosis

        13.3.5. Tricuspid Regurgitation

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Cardiac Catheterization Laboratories

        13.4.3. Ambulatory Surgical Centers

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Procedure

        13.6.2. By Indication

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Procedure, 2017–2031

        14.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        14.2.2. Transcatheter Mitral Valve Repair (TMVR)

        14.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

    14.3. Market Value Forecast, by Indication, 2017–2031

        14.3.1. Aortic Stenosis

        14.3.2. Mitral Regurgitation

        14.3.3. Aortic Regurgitation

        14.3.4. Mitral Stenosis

        14.3.5. Tricuspid Regurgitation

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Cardiac Catheterization Laboratories

        14.4.3. Ambulatory Surgical Centers

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Procedure

        14.6.2. By Indication

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. Abbott Laboratories

            15.3.1.1. Company Overview

            15.3.1.2. Procedure Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Edwards Lifesciences Corporation

            15.3.2.1. Company Overview

            15.3.2.2. Procedure Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Boston Scientific Corporation

            15.3.3.1. Company Overview

            15.3.3.2. Procedure Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. B. Braun Melsungen AG

            15.3.4.1. Company Overview

            15.3.4.2. Procedure Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Medtronic plc

            15.3.5.1. Company Overview

            15.3.5.2. Procedure Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Meril Life Sciences

            15.3.6.1. Company Overview

            15.3.6.2. Procedure Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Sahajanand Medical Technologies Limited

            15.3.7.1. Company Overview

            15.3.7.2. Procedure Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. MicroPort Scientific Corporation

            15.3.8.1. Company Overview

            15.3.8.2. Procedure Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Venus Medtech (Hangzhou) Inc.

            15.3.9.1. Company Overview

            15.3.9.2. Procedure Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.

            15.3.10.1. Company Overview

            15.3.10.2. Procedure Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

        15.3.11. Peijia Medical Limited

            15.3.11.1. Company Overview

            15.3.11.2. Procedure Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Financial Overview

            15.3.11.5. Strategic Overview

        15.3.12. Blue Sail Medical Co., Ltd.

            15.3.12.1. Company Overview

            15.3.12.2. Procedure Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Financial Overview

            15.3.12.5. Strategic Overview

List of Tables

Table 01: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 02: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 03: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 07: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 08: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 11: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 12: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 15: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 16: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 19: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 20: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 23: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 24: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

Figure 02: Global Transcatheter Heart Valve Replacement & Repair Market Revenue (US$ Mn), by Procedure, 2022

Figure 03: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by Procedure, 2022

Figure 04: Global Transcatheter Heart Valve Replacement & Repair Market Revenue (US$ Mn), by Indication, 2022

Figure 05: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by Indication, 2022

Figure 06: Global Transcatheter Heart Valve Replacement & Repair Market Revenue (US$ Mn), by End-user, 2022

Figure 07: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by End-user, 2022

Figure 08: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by Region, 2022

Figure 09: Global Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast, 2017–2031

Figure 10: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 11: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023-2031

Figure 12: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031

Figure 13: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023-2031

Figure 14: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031

Figure 15: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023-2031

Figure 16: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Region, 2022 and 2031

Figure 17: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Region, 2023-2031

Figure 18: North America Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 19: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country, 2017–2031

Figure 20: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country, 2022 and 2031

Figure 21: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 22: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031

Figure 23: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031

Figure 24: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 25: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031

Figure 26: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023-2031

Figure 27: Europe Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 29: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 30: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 31: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031

Figure 32: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031

Figure 33: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 34: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031

Figure 35: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031

Figure 36: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 37: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 38: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 39: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 40: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031

Figure 41: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031

Figure 42: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 43: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031

Figure 44: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031

Figure 45: Latin America Transcatheter Heart Valve Replacement & Repair Market Value(US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 46: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 47: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 48: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 49: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031

Figure 50: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031

Figure 51: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 52: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031

Figure 53: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031

Figure 54: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 55: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 56: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 57: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 58: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031

Figure 59: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031

Figure 60: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 61: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031

Figure 62: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved